Information on this page is intended for Ireland healthcare professionals only and may contain promotional material
Tillotts IDEAL is an educational initiative developed by Tillotts to support both new and experienced healthcare professionals to improve their knowledge surrounding Clostridioides difficile infection (CDI) to support our healthcare colleagues improve patient care.
Tillotts IDEAL Education is an educational initiative organised and funded by Tillotts Pharma UK and Ireland. Tillotts Products may be discussed in the content of these modules
Free access to interactive online modules & resources for CDI education
Register here
Introduction
Clostridioides difficile infection (CDI) is the most common cause of infectious hospital-onset diarrhoea1. This diarrhoea can be life-threatening and is associated with significant morbidity, mortality and financial burden.2
Working alongside key opinion leaders in the infection prevention field, Tillotts identified a need for educational resources to further develop healthcare professionals knowledge of CDI.
IDEAL has been developed using our experience from the nine years of upskilling healthcare professionals working in Inflammatory Bowel Disease (IBD) through the Tillotts LOGIC Education program. Tillotts is committed to working with our healthcare colleagues to help improve outcomes for CDI patients.
Modules include
Introduction to CDI
The symptoms, how the infection is transmitted, risk factors as well as an overview of treatment and prevention measures.
30 minutes
Introduction to CDI
The symptoms, how the infection is transmitted, risk factors as well as an overview of treatment and prevention measures.
30 minutes
Assessment of acute diarrhoea: NICE guidelines
Management of acute diarrhoea in adults; how adults should be assessed, guidance on how acute diarrhoea should be investigated in primary care and information on sending a stool sample for testing.
30 minutes
Assessment of acute diarrhoea: NICE guidelines
Management of acute diarrhoea in adults; how adults should be assessed, guidance on how acute diarrhoea should be investigated in primary care and information on sending a stool sample for testing.
30 minutes
Antibiotics for CDI
The antimicrobial treatments used for CDI, including the mechanism of action of the different treatments and the NICE guidelines.
30 minutes
Antibiotics for CDI
The antimicrobial treatments used for CDI, including the mechanism of action of the different treatments and the NICE guidelines.
30 minutes
Human Burden of CDI
The toll CDI can have on patients, including an overview of the complications that can occur and impact on quality of life, presenting compelling study data and poignant testimonials from CDI patients.
14 minutes
Human Burden of CDI
The toll CDI can have on patients, including an overview of the complications that can occur and impact on quality of life, presenting compelling study data and poignant testimonials from CDI patients.
14 minutes
CDI Epidemiology
An overview of the incidence of CDI in the UK as well as the risk factors for CDI and those groups who can be considered high risk.
30 minutes
CDI Epidemiology
An overview of the incidence of CDI in the UK as well as the risk factors for CDI and those groups who can be considered high risk.
30 minutes
Genetic characterisation of C.diff
An overview of the genetics of C. difficile and PCR ribotyping, prevalent C. difficile ribotypes and information on the C. difficile ribotyping network.
30 minutes
Genetic characterisation of C.diff
An overview of the genetics of C. difficile and PCR ribotyping, prevalent C. difficile ribotypes and information on the C. difficile ribotyping network.
30 minutes
CDI diagnosis and testing
Signs and symptoms of CDI and the differential diagnosis of diarrhoea, who to test, as well as further details on the different laboratory tests used in CDI diagnosis and what these test results indicate.
25 minutes
CDI diagnosis and testing
Signs and symptoms of CDI and the differential diagnosis of diarrhoea, who to test, as well as further details on the different laboratory tests used in CDI diagnosis and what these test results indicate.
25 minutes
C. diff Decoded: Insights from experts
Leading experts break down key clinical research to provide clear, practical insights.
30 minutes
C. diff Decoded: Insights from experts
Leading experts break down key clinical research to provide clear, practical insights.
30 minutes
Patient and carer stories of C.diff
Real-life stories that explore the impact on the quality of life of a carer looking after her father who had a CDI diagnosis and a patient who experienced CDI.
18 minutes
Patient and carer stories of C.diff
Real-life stories that explore the impact on the quality of life of a carer looking after her father who had a CDI diagnosis and a patient who experienced CDI.
18 minutes
An Introduction to Antimicrobial Stewardship
An introduction to Antimicrobial Stewardship (AMS) with a focus on AMS principles. Define AMS and understand its importance in addressing antimicrobial resistance (AMR) and healthcare-associated infections like Clostridioides difficile infection (CDI).
1 hour
An Introduction to Antimicrobial Stewardship
An introduction to Antimicrobial Stewardship (AMS) with a focus on AMS principles. Define AMS and understand its importance in addressing antimicrobial resistance (AMR) and healthcare-associated infections like Clostridioides difficile infection (CDI).
1 hour
Overview of CDI
(CPD Certified)
An overview of CDI and its management, covering symptoms and complications, early identification and safe patient placement, transmission, risk factors, prevention, and treatment of Clostridioides difficile infection.
1 hour
Overview of CDI
(CPD Certified)
An overview of CDI and its management, covering symptoms and complications, early identification and safe patient placement, transmission, risk factors, prevention, and treatment of Clostridioides difficile infection.
1 hour
Managing CDI in Vulnerable Patients
Clinician-led insights into the management of CDI in high-risk patients. Expert healthcare professionals share real-world strategies for recognising, treating, and supporting patients with conditions such as inflammatory bowel disease (IBD) and chronic kidney disease (CKD).
1 hour
Managing CDI in Vulnerable Patients
Clinician-led insights into the management of CDI in high-risk patients. Expert healthcare professionals share real-world strategies for recognising, treating, and supporting patients with conditions such as inflammatory bowel disease (IBD) and chronic kidney disease (CKD).
1 hour
CDI Webinar Series
This module is divided into various training videos which cover everyday clinical practice and the latest topics in Clostridioides difficile infection featuring guest speakers.
1 hour each
CDI Webinar Series
This module is divided into various training videos which cover everyday clinical practice and the latest topics in Clostridioides difficile infection featuring guest speakers.
1 hour each
To begin learning through IDEAL please visit the Tillotts eLearning platform
Tillotts eLearning
- 1. Health Service Executive. (2022) Available at: C.diff. https://www2.hse.ie/conditions/c-diff/ [Accessed June 2025]
- 2. Tresman R & Goldenberg S. J Antimicrob Chemother 2018;73:2851-2855.
PM-TP-UK-00002 | July 2026
The information on the following pages is only intended for patients within Ireland who have been prescribed Asacolon, Dificlir or Entocort CR 3 mg Capsules
Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie/report-an-issue/medicines-for-human-use/side-effects.
Adverse events should also be reported to Tillotts Pharma UK and Ireland on +353 1 2942015 or pvireland@tillotts.com
You are about to leave tillotts.ie for an external website. Tillotts is not responsible for the content of other websites.
